Sanofi’s diabetes drug Soliqua launched in India
A once-daily solution that breaks through the complexity of living with type 2 diabetes
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
type-2 diabetes mellitus
Glenmark launches biosimilar of anti-diabetic drug, Liraglutide, in India
It is priced at around Rs 100 for a standard dose of 1.2 mg (per day)
Indoco Remedies gets tentative USFDA approval for Canagliflozin Tablets
Canagliflozin improves glycemic control in adults with type 2 diabetes mellitus
Unichem Labs gets tentative US FDA approval for Sitagliptin Tablets USP
Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes…
Granules India gets USFDA approval of Metformin Hydrochloride ER Tablets
Metformin Hydrochloride ER Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with…
Zydus Cadila gets tentative US FDA approval for Dapagliflozin Tablets
Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated to improve glycemic control in adults with type 2…
Marksans Pharma expands recalls of metformin hydrochloride tablets
It is due to NDMA content in some lots that exceed the acceptable daily intake limit of 96ng/day
Zydus Cadila gets tentative USFDA nod for empagliflozin and linagliptin tablets
They are oral diabetes medicines that help control blood sugar levels
Lupin gets tentative approval from US FDA for empagliflozin tablets
Empagliflozin tablets are used to treat type 2 diabetes mellitus as an adjunct to diet and exercise
Linagliptin demonstrates cardiovascular and renal safety in Asian adults with type 2 diabetes
In a sub-analysis of the CAROLINA cardiovascular outcome trial, linagliptin demonstrated no increased cardiovascular risk versus…